title: Retinal vascular precipitates during administration of melphalan into the ophthalmic artery.
authors.forename: Rosanne
authors.initials: R
authors.lastname: Superstein
authors.forename: David
authors.initials: D
authors.lastname: Lederer
authors.forename: Josee
authors.initials: J
authors.lastname: Dubois
authors.forename: Patrick
authors.initials: P
authors.lastname: Hamel
authors.forename: Anne-Sophie
authors.initials: AS
authors.lastname: Carret
authors.forename: Sonia
authors.initials: S
authors.lastname: Callejo
mesh_terms: D018906:Antineoplastic Agents, Alkylating / Q000009:adverse effects*; D004596:Electroretinography; D006801:Humans; D007223:Infant; D007261:Infusions, Intra-Arterial; D007511:Ischemia / Q000139:chemically induced / Q000503:physiopathology; D008297:Male; D008558:Melphalan / Q000009:adverse effects*; D009880:Ophthalmic Artery / Q000187:drug effects*; D012160:Retina / Q000502:physiology; D015356:Retinal Artery Occlusion / Q000139:chemically induced* / Q000503:physiopathology; D019572:Retinal Neoplasms / Q000188:drug therapy / Q000503:physiopathology; D012170:Retinal Vein Occlusion / Q000139:chemically induced* / Q000503:physiopathology; D012175:Retinoblastoma / Q000188:drug therapy / Q000503:physiopathology
chemical_list: D018906:Antineoplastic Agents, Alkylating; D008558:Melphalan